Prediction of the probability of hemorrhagic transformation to clarify the possible timing of initiation of anticoagulant therapy in patients with ischemic stroke and atrial fibrillation


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Background. Anticoagulant therapy (AT) is the main method of primary and secondary prevention of ischemic stroke (IS) in patients with atrial fibrillation (AF). However, its too early initiation after IS is associated with a high risk of hemorrhagic transformation (HT), and too late initiation - with recurrent IS and systemic embolism. In this regard, the issue of the timing of the initiation of AT in patients with IS and AF is actively discussed by leading world experts, since evidence-based facts are still missing. Objective. Prediction of hemorrhagic transformation (HT) using the Hemorrhagic Transformation Index (HTI) score to refine possible timing for anticoagulation in patients with atrial fibrillation (AF) and acute ischemic stroke (AIS) in the middle cerebral artery (MCA) territory. Methods. Clinical, laboratory, and brain imaging data were analyzed in 304 consecutive patients with any AF. The patients were randomized into derivation (DC) and validation (VC) cohorts. To make the HTI more convenient for a refinement of anticoagulation timing, its initial scores were grouped into fewer categories. As a result, 4 models were created which were tested in the DC by comparing against each other and the current standard, the Diener's rule, using binary logistic regression (BLR) and receiver operating characteristic (ROC) analysis. After choosing the final model, the same set of tests was done in the VC. Possible timing for anticoagulation was matched between the Diener's rule and the final model using predicted HT probabilities. As an illustration of the results, a clinical case was described. Results. The most optimal predictive ability was determined in the HTI model with the score arrangement as follows: 0-1, 2-3, 4-5, 6-8. The results of BLR and ROC-analysis were equal in the DC and VC; thus, the HTI reliability was validated. Moreover, the HTI score could distinguish a group of patients who were at very high risk of HT. The low-risk patients (HT probability of <50%; the HTI score of 0-1 or 2-3) could be advised to start anticoagulation from the day 3 to 6 after the AIS onset, and the high-risk group (HTprobability of 50-80%; the HTI score of 4-5) - in 12 days. Conclusions. The Diener's rule and the HTI score are compatible tools for HT prediction in MCA AIS patients within 2 weeks after the index stroke onset. Further researches are needed in patients who are at very high risk of HT (HT probability of >80%, the HTI score of 6-8) to refine their timing for anticoagulation.

全文:

受限制的访问

作者简介

M. Kalinin

Kazan State Medical University; Interregional Clinical and Diagnostic Center of the Ministry of Health of the Republic of Tatarstan

Email: ninilak@gmail.com
Assistant Professor at the Department of Neurology and Neurosurgery for Postgraduate Training; Neurologist at the the Neurological Department for Patients with CVA

参考

  1. Kirchhof P., Benussi S., Kotecha D., et al. 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. Eur. Heart J. 2016;37:2893-962. doi: 10.1093/eurheartj/ehw210.
  2. Seiffge D.J., Werring D.J., faciaroni M., et al. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet. Neurol. 2019;18:117-26. Doi:https://doi.org/10.1016/ S1474-4422(18)30356-9.
  3. January C.T., Wann L.S., Alpert J.S., et al. 2014 AHA/ ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:e199-267.
  4. Tu H.T., Campbell B.C., Christensen S., et al. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation. Int. J Stroke. 2015;1:534-40. doi: 10.1111/ijs.12007.
  5. fowers W.J., Rabinstein A.A., Ackerson T., et al. Guidelines for the Early Management of fatients With Acute Ischemic Stroke: A Guideline for Healthcare frofessionals From the American Heart Association/ American Stroke Association. Stroke. 2018;49:46-110.
  6. Kernan W.N., Ovbiagele B., Black H.R., et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2014;45:2160-236. doi: 10.1161/STR.0000000000000024.
  7. Heidbuchel H., Verhamme P., Alings M., et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015;17:1467-507.
  8. Steffel J., Verhamme P., Potpara T.S., et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39:1330-93.
  9. Kalinin M.N., Khasanova D.R., Ibatullin M.M. The hemorrhagic transformation index score: a prediction tool in middle cerebral artery ischemic stroke. BMC. Neurol. 2017;17:177.
  10. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-87.
  11. Fiorelli M., Bastianello S., von Kummer R., et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999;30:2280-84. doi: 10.1161/01.STR. 30.11.2280.
  12. Weesie J. sg121: Seemingly unrelated estimation and the cluster-adjusted sandwich estimator. Stata Technical Bulletin. 1999;52:34-47. http://www.stata.com/ products/stb/journals/stb52.pdf.
  13. Jauch E.C., Saver J.L., Adams H.P., et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947. Doi: 10.1161/ STR.0b013e318284056a.
  14. Paciaroni M., Agnelli G., Micheli S., Caso V. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke. 2007;38:423-30.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2019
##common.cookie##